From Yahoo Finance: 2025-04-15 07:35:00

Investors are increasingly turning to dividend-focused strategies for portfolio stability amid market volatility. US-listed dividend ETFs saw a surge in net inflows, highlighting a renewed interest in dividends. Stable cash flows from dividend-paying stocks offer a buffer during uncertain economic times, making them a preferred choice for all-weather portfolios.

Dividend-paying stocks have historically shown defensive qualities, offering a cushion during market downturns while still providing upside potential. Dividend stocks have experienced lower volatility and smaller drawdowns compared to the broader market, particularly during times of economic uncertainty and market turbulence.

Bristol-Myers Squibb Company (NYSE:BMY) is among the best value dividend stocks according to billionaires, with a forward P/E ratio of 7.50 as of April 13. The pharmaceutical company focuses on innovative medicines and has a robust growth strategy centered around its neuroscience drug, Cobenfy. Investors seeking income and growth opportunities may find BMY an attractive investment option.

Bristol-Myers Squibb Company (NYSE:BMY) continues to be an appealing choice for income-seeking investors, with a steady dividend policy and strong revenue drivers like Cobenfy and Breyanzi. The company’s growth portfolio saw a significant increase in revenue during the fourth quarter, making it an attractive entry point for investors looking for value stocks with growth potential.

Bristol-Myers Squibb Company (NYSE:BMY) declared a quarterly dividend of $0.62 per share on March 3, maintaining its track record of consistent payouts for 16 years. With a dividend yield of 4.89% as of April 13, BMY offers a reliable income stream for investors. While BMY ranks high on the list of best value dividend stocks, there may be other deeply undervalued stocks with greater potential for higher returns in the short term.

Read more: Among the Best Value Dividend Stocks to Buy According to Billionaires?